Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_0965 |
Primary information | |
---|---|
B3PDB ID | b3pdb_0965 |
Peptide Name | ANG1005 |
PEPTIDE SEQUENCE (1-letter) | (2'-N-succinimide-paclitaxel)TFFYGGSRG-(2'-N-succinimide-paclitaxel)KRNNF(2'-N-succinimide-paclitaxel)KTEEY |
PEPTIDE SEQUENCE (3-letter) | (2'-N-succinimide-paclitaxel)Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-(2'-N-succinimide-paclitaxel)Lys-Arg-Asn-Asn-Phe-(2'-N-succinimide-paclitaxel)Lys-Thr-Glu-Glu-Tyr |
N-terminal modification | NA |
C-terminal modification | NA |
Chemical modification | NA |
Peptide Length | 19 |
Conformation | Linear |
Peptide Nature | NA |
Source/Origin of peptide | Chemically synthesized |
SMILES | NA |
Cell Line | NA |
In vitro CONCENTRATION | NA |
In vitro METHOD | Capillary deplition in situ b p |
In vitro RESULT | NA |
ANIMAL MODEL | NA |
In vivo CONCENTRATION | NA |
In vivo MODE OF DELIVERY | NA |
In vivo METHOD | NA |
In vivo RESULT | NA |
ACTION | NA |
TRANSPORT TYPE | NA |
SUBCELLULAR LOCALISATION | NA |
COMBINATION | NA |
PHYSICAL CONDITION | NA |
RESPONSE | CD(capillary/perfusate) |
RESULT | 0.3111 ml/g |
LABEL | H3/C14 |
PMID | 18574456 |